Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1991 3
1992 1
1993 1
1994 2
1996 4
1997 1
1998 1
1999 3
2000 2
2001 2
2002 5
2003 5
2004 2
2005 4
2006 10
2007 9
2008 3
2009 8
2010 11
2011 12
2012 10
2013 12
2014 10
2015 11
2016 10
2017 22
2018 18
2019 9
2020 17
2021 15
2022 20
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D, Baldomero H, Medinger M, Masouridi-Levrat S, Schanz U, Nair G, Güngör T, Halter J, Passweg JR, Chalandon Y; Swiss Stem Cell Transplantation Group (SBST). Heim D, et al. Among authors: schanz u. Swiss Med Wkly. 2024 May 3;154:3754. doi: 10.57187/s.3754. Swiss Med Wkly. 2024. PMID: 38749067 Free article.
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Scheid C, Eikema DJ, Van Gelder M, Salmenniemi U, Maertens J MD, Passweg JR, Blaise D, Byrne JL, Kroeger N, Sockel K, Chevallier P, Bourhis JH, Cornelissen JJ, Sengeloev H, Finke J, Snowden JA, Gedde-Dahl T, Cornillon J, Schanz U, Patel A, Koster L, de Wreede LC, Hayden PJ, Raj K, Drozd-Sokolowska J, Gurnari C, Onida F, McLornan DP, Robin M, Yakoub-Agha I. Scheid C, et al. Among authors: schanz u. Blood. 2024 May 10:blood.2023022273. doi: 10.1182/blood.2023022273. Online ahead of print. Blood. 2024. PMID: 38728380
Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
Kusejko K, Neofytos D, van Delden C, Hirsch HH, Meylan P, Boggian K, Hirzel C, Garzoni C, Sidler D, Schnyder A, Schaub S, Golshayan D, Haidar F, Bonani M, Kouyos RD, Mueller NJ, Schreiber PW; Swiss Transplant Cohort Study. Kusejko K, et al. Open Forum Infect Dis. 2024 Feb 6;11(3):ofae055. doi: 10.1093/ofid/ofae055. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38464489 Free PMC article.
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.
Seydoux C, Uppugunduri CRS, Medinger M, Nava T, Halter J, Heim D, Chalandon Y, Schanz U, Nair G, Cantoni N, Passweg JR, Ansari M. Seydoux C, et al. Among authors: schanz u. Bone Marrow Transplant. 2024 Feb;59(2):294. doi: 10.1038/s41409-023-02166-2. Bone Marrow Transplant. 2024. PMID: 38129515 Free PMC article. No abstract available.
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.
Ben Hassine K, Seydoux C, Khier S, Daali Y, Medinger M, Halter J, Heim D, Chalandon Y, Schanz U, Nair G, Cantoni N, Passweg JR, Satyanarayana Uppugunduri CR, Ansari M. Ben Hassine K, et al. Among authors: schanz u. Transplant Cell Ther. 2024 Mar;30(3):332.e1-332.e15. doi: 10.1016/j.jtct.2023.12.003. Epub 2023 Dec 9. Transplant Cell Ther. 2024. PMID: 38081414 Free article.
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Passweg JR, Baldomero H, Ansari M, Arber C, Chalandon Y, Daskalakis M, Diepold M, Diesch-Furlanetto T, Duchosal MA, Gerull S, Güngör T, Heim D, Hitz F, Holbro A, Masouridi-Levrat S, Nair G, Novak U, Pabst T, Renner C, Stussi G, Schneidawind D, Schanz U, Wannesson L, Halter JP; Swiss Blood Stem Cell Transplantation Group (SBST). Passweg JR, et al. Among authors: schanz u. Hematol Oncol. 2024 Jan;42(1):e3241. doi: 10.1002/hon.3241. Epub 2023 Dec 6. Hematol Oncol. 2024. PMID: 38058031
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
Penack O, Peczynski C, Koenecke C, Polge E, Sanderson R, Yakoub-Agha I, Fegueux N, Daskalakis M, Collin M, Dreger P, Kröger N, Schanz U, Bloor A, Ganser A, Besley C, Wulf GG, Novak U, Moiseev I, Schoemans H, Basak GW, Chabannon C, Sureda A, Glass B, Peric Z. Penack O, et al. Among authors: schanz u. Front Immunol. 2023 Sep 27;14:1252811. doi: 10.3389/fimmu.2023.1252811. eCollection 2023. Front Immunol. 2023. PMID: 37828980 Free PMC article.
Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm.
Rieger MJ, Stolz SM, Müller AM, Schwotzer R, Nair G, Schneidawind D, Manz MG, Schanz U. Rieger MJ, et al. Among authors: schanz u. Bone Marrow Transplant. 2023 Oct;58(10):1121-1129. doi: 10.1038/s41409-023-02042-z. Epub 2023 Jul 21. Bone Marrow Transplant. 2023. PMID: 37479752 Free PMC article.
226 results